Skip to main content

Day: August 24, 2021

Centrifugal Pump Market to Reach USD 50.32 Billion and Rise at 4.3 % CAGR; Increasing Number of Building Activities for Residential and Commercial Sector to Support Growth: Fortune Business Insights™

Key companies covered in the Centrifugal Pump Market Research report include Kirloskar Brothers Limited, ITT Inc., The Weir Group PLC, Sulzer, Wilo Group, GRUNDFOS, Xylem, Flowrox, KSB Company, Flowserve Corporation, Ebara Corporation, Dover Corporation, Tsurumi Pump. Pune, India, Aug. 24, 2021 (GLOBE NEWSWIRE) — The global centrifugal pump market size is anticipated to reach USD 50.32 billion by 2026 owing to the rapid development of the commercial and centrifugal infrastructure worldwide. A centrifugal pump is a mechanical device that uses a simple mechanism for drawing up liquid from a high or low level. This is possible by converting rotational energy from a motor to energy in the moving liquid. According to a recently published report by Fortune Business Insights™ titled, “Centrifugal Pumps Market Size, Share & Industry...

Continue reading

Exel Industries: Shares and voting rights 31.07.2021

   EXEL Industries A French public limited company (Société Anonyme) with a share capital of €16,969,750 Registered office:– France Reims Companies Register (RCS): No. B 095 550 356       Disclosure of the number of shares and voting rights comprising the share capital          Date Total number of shares comprising the share capital Total number of voting rightsJuly, 31, 2021 6 787 900 Total gross voting rights : 10 855 045Total net* voting rights : 10 608 304  * Total net amount = total amount of voting rights attached to the total number of shares minus those shares that do not carry voting rights (treasury shares).                          2.13.0.0AttachmentEXEL Industries Droits de vote 31.07.2021 EN

Continue reading

Better Collective reports record revenue; strong growth in US business and media partnerships

Regulatory Release no. 27/2021 August 24, 2021   Interim report January 1 – June 30, 2021 Highlights second quarter 2021Q2 Group revenue grew by 162% to 40,009 tEUR (Q2 2020: 15,253 tEUR). Organic revenue growth was 47%. The US business performed strongly, even before inclusion of Action Network, by recording NDC performance and revenue on par with a strong Q1 2021, despite Q2 being low season. Q2 Group EBITDA before special items increased 90% to 12,662 tEUR (Q2 2020: 6,672 tEUR). The EBITDA-margin before special items was 32% (Publishing segment 43% and Paid Media segment 11%). Special items include cost related to the acquisition of Action Network of 5.3 mEUR. Cash Flow from operations before special items was 11,069 tEUR (Q2 2020: 10,363 tEUR), an increase of 7%. The cash conversion was 93% following a 121% conversion rate...

Continue reading

BW Offshore: Second Quarter and First Half Result 2021

Second Quarter and First Half Result 2021 HIGHLIGHTSEBITDA of USD 91.1 million in Q2 and USD 201.9 million for the first half of 2021 Operating cashflow of USD 133.7 million in Q2 and USD 204.9 million for the first half of 2021 Equity ratio of 39.9% and USD 279.7 million in available liquidity at 30 June Barossa FPSO project on track with first steel cut for hull planned for September 2021   USD 1.15 billion bank financing for Barossa FPSO near completion Quarterly dividend of USD 0.035 per share              In the second quarter, BW Offshore continued to make significant progress in executing the dual-track strategy of evolving the core FPSO business and capturing energy transition opportunities by developing adjacent business areas. EBITDA for the second quarter of 2021 was USD 91.1 million, a decrease from USD 110.8 million in...

Continue reading

Novartis provides update on BELINDA study investigating Kymriah® as second-line treatment in aggressive B-cell non-Hodgkin lymphoma

Phase III BELINDA study did not meet primary endpoint of event-free survival for patients with aggressive B-cell non-Hodgkin lymphoma who had primary refractory disease or who relapsed within 12 months of first-line treatmentNovartis CAR-T innovation continues to accelerate development of next-generation platform with improved CAR-T cellular characteristics, high speed, lower cost of goods sold (COGS) and advancement of clinical research into new indications and targets; early clinical data anticipated at upcoming medical meetingIn its approved indications, Kymriah is an efficacious treatment offering potential for durable responses and a favorable safety profile based on clinical and real-world experience in more than 5,300 patients to dateKymriah demonstrated strong response rates and a remarkable safety profile in relapsed...

Continue reading

Boskalis: Strong operational half year and positive outlook

Papendrecht, 24 August 2021 KEY FIGURES FIRST HALF YEAR 2021Revenue: EUR 1.32 billion (H1 2020: EUR 1.26 billion) EBITDA: EUR 226 million (H1 2020: EUR 204 million) Net profit: EUR 72 million (H1 2020: loss EUR 96 million) Order book: EUR 5.53 billion (End of 2020: EUR 5.31 billion)OUTLOOK SECOND HALF OF 2021Dredging: busy second half of the year with good fleet utilization Offshore Energy: similar picture to the first half of the year Towage & Salvage: Towage stable. Salvage operationally unpredictable; no major settlement results EBITDA outlook second half year: in line with first half yearRoyal Boskalis Westminster N.V. (Boskalis) has concluded a good half year with a strong increase in earnings despite ongoing COVID-19 related restrictions.  Compared to last year, revenue increased by 4.6% to EUR 1.32 billion (H1 2020:...

Continue reading

Trifork Group reports revenue growth of 55% in Q2 and 46% in H1 2021, narrows full year guidance in top of range.

Company announcement no. 25 / 2021 Schindellegi, Switzerland – 24 August 2021 Trifork Group – Report of the quarter ending 30. June 2021 Trifork Group reports revenue growth of 55% in Q2 and 46% in H1 2021, narrows full year guidance in top of range. Second quarter 2021Revenue of Trifork Group in the the second quarter of 2021 was EURm 39.9, an increase of 54.9% compared to the same period in 2020. Organic growth amounted to 24.8% and was driven by the Public sector and Fintech in both the Trifork Build and Run sub-segments, whereas inorganic growth primarily resulted from the acquisition of Nine. Trifork segment adjusted EBITDA in Q2 2021 amounted to EURm 7.3 an increase of 91.8% from EURm 3.8 in Q2 2020, corresponding to an adjusted EBITDA margin of 18.4%, up from 14.8%. By the end of Q2 2021, the Inspire sub-segment reached a cumulative...

Continue reading

Evs Reports First Half 2021 Results

Publication on August 24, 2021, before market openingRegulated information – Press release first half 2021 resultsEVS Broadcast Equipment S.A.: Euronext Brussels (EVS.BR), Bloomberg (EVS BB), Reuters (EVSB.BR) EVS REPORTS FIRST HALF 2021 RESULTSPreparing to deliver strong results in 2021 During the first semester, EVS has experienced its best H1 revenue and profit generation of the last 5 years while also further growing a solid order book for the future. These H1 revenues are based on a continuous and even accelerated growth in the LAB market pillar and an after-Covid catch-up in the LSP market pillar, with some of the customers recovering their investments to deliver the one-year delayed summer events and some peak of events packed at the same time. H1 Financial performanceRevenue in the first six months of the year, amounts to EUR...

Continue reading

Endexx’s International Division, Go Green Global, Initiates Soft-Launch of its Herb House Dispensary in Ocho Rios, Jamaica

Cave Creek, AZ, Aug. 23, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Endexx Corporation (OTC: EDXC), a provider of innovative Hemp-derived wellness and nutritional products, is pleased to announce the soft launch of a new “Herb House” in Ocho Rios, Jamaica through its international subsidiary, Go Green Global Enterprises, Inc. (G3) and its partner Go Green Global Limited (a Jamaican Corporation). In the heart of the Taj Mahal Shopping Center in Ocho Rios and as a year-round tourist destination, the store is now unveiled as Go Green Global’s first licensed store to carry premium medical marijuana, “ganja”, and other superior products available for purchase. The store features an Herb House Lounge for on-site consumption, products for sale, and serve as a premium location for customers to experience and enjoy while shopping....

Continue reading

StoneCastle Financial Corp. Releases Month End Estimated Net Asset Value as of July 2021

DENVER, Aug. 23, 2021 (GLOBE NEWSWIRE) — StoneCastle Financial Corp., (NASDAQ:BANX) (“StoneCastle Financial” or the “Company”), today announced that the Company’s estimated and unaudited Net Asset Value (“NAV”) as of July 31, 2021 was $21.92. The NAV was up $0.12 from the prior month-end. This estimated NAV is not a comprehensive statement of our financial condition or results for the month ended July 31, 2021. We advise you that our unaudited NAV per share for the third quarter ending September 30, 2021 will be released as part of our normal quarterly earnings reporting process and may differ materially from this estimated NAV. About StoneCastle Financial Corp. StoneCastle Financial is an SEC registered non-diversified, closed-end investment company listed on the NASDAQ Global Select Market under the symbol “BANX.”...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.